Singh Neeraj, Ritaccio Anthony
Epilepsy Division, Department of Neurology, Albany Medical Center, United States of America.
Department of Neurology, Mayo Clinic Florida, United States of America.
Epilepsy Behav Rep. 2020 Jan 7;13:100355. doi: 10.1016/j.ebr.2019.100355. eCollection 2020.
This paper reports the electroclinical manifestations of an epilepsy syndrome associated with a chromodomain helicase DNA-binding protein 2 (CHD2) gene mutation with clinical semiology and electroencephalographic (EEG) features consistent with juvenile myoclonic epilepsy (JME). Myoclonic and myoclonic-tonic-clonic seizures, as well as generalized 4- to 5-Hz high-amplitude spike-wave and polyspike-wave discharges, were well characterized in an adolescent. However, the atypical age of onset, developmental disability, and apparent drug resistance led to suspicion of an alternative etiology for epilepsy, subsequently verified as a CHD2 gene mutation. When atypical features are present, a JME mimic should be suspected in the differential diagnosis of the more established syndrome of JME.
本文报告了一种与染色质结构域解旋酶DNA结合蛋白2(CHD2)基因突变相关的癫痫综合征的电临床表现,其临床症状学和脑电图(EEG)特征与青少年肌阵挛性癫痫(JME)一致。在一名青少年中,肌阵挛发作、肌阵挛-强直-阵挛发作以及4至5赫兹的广泛性高波幅棘波和多棘波放电均得到了很好的特征描述。然而,非典型的发病年龄、发育障碍和明显的耐药性导致怀疑癫痫有其他病因,随后证实为CHD2基因突变。当出现非典型特征时,在JME这个更明确的综合征的鉴别诊断中应怀疑有JME模仿综合征。